ESSA Pharma Inc.
EPIX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $75 | $70 | $79 | $269 |
| - Cash | $86 | $86 | $93 | $104 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$10 | -$16 | -$14 | $165 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$5 | -$6 | -$9 | -$6 |
| % Margin | – | – | – | -4,664.6% |
| Net Income | -$4 | -$6 | -$9 | -$6 |
| % Margin | – | – | – | -4,681.4% |
| EPS Diluted | -0.09 | -0.14 | -0.19 | -0.14 |
| % Growth | 35.6% | 26.3% | -35.7% | – |
| Operating Cash Flow | -$4 | -$7 | -$6 | -$3 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$4 | -$7 | -$6 | -$3 |